Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 34-05 / SWOG 0230 (POEMS) 

Phase III of LHRH analog administration during chemotherapy to reduce ovarian failure following chemotherapy in early stage, hormone-receptor breast cancer

Prevention Of Early Menopause Study - POEMS

DESIGN

Please click on the picture to see a larger version

Note: Participation in an adjuvant treatment trial does not, in general, exclude patients from POEMS.
If you would like to register patients from IBCSG 22-00 also into POEMS, those randomized into Arm A of IBCSG 22-00 would be eligible. Only patients randomized to the maintenance therapy arm would not be eligible for POEMS. Patients could, therefore, only participate in both studies if, following randomization to the standard arm, a one week delay before starting chemotherapy (which is required if randomized to the intervention arm on POEMS) is permissible.

Results & Publications


Presentations

  • POEMS Prevention Of Early Menopause (November 2006)

Study Chairs
IBCSG: Dr. Kelly-Anne Phillips - Melbourne, Australia
SWOG: Dr. Halle C. F. Moore - Cleveland, USA

Statistician
Prof. RIchard Gelber

Trial Coordinators
Ann Lange, Emma MacDonald
Frontier Science (Scotland) Ltd.
Grampian View
Kincraig, Kingussie
PH21 1NA
Phone: +44 1540 651 000
Fax: +44 1540 651 007
Email: s0230@frontier-science.uk

Date of Activation
March 15, 2006

Targeted Accrual
416 patients

Results Publications Results & Publications


News

01.02.2010:
The impact of peritumoral vascular invasion on outcome in IBCSG Trials VIII and IX

27.01.2010:
First issue of SOLE flash, the short newsletter for IBCSG 35-07 SOLE

11.01.2010:
The latest information about the IBCSG Annual Meeting 2010 is available online.

All News

 
  Print